Cliff Pavlovic is one of the founders, as well as Vice-President, of BioTech Annecto (previously known as BioTech Montréal). Launched in Montréal in 2009, it is a social networking organization whose aim is to bring together entrepreneurs, investors, scientists, attorneys, journalists and other professionals in the biotechnology sector (including pharmaceutical, healthcare and biomedical, cosmetics, agribusiness, and environmental). This is done by inviting people, one day every month, from the local biotechnology community to meet at trendy locations around town. This allows regular communication and exchanges
between industry, the public sector and academia. The events have expanded to Toronto, Ottawa, Paris, and Vancouver.
The author of a comparative study between tech transfer in Québec and in Flanders, Cliff has also been involved in the knowledge and innovation economy: Lastly as an Intellectual Property Rights Officer at KU Leuven Research & Development, the technology transfer unit of KU Leuven University (Leuven, Belgium), and as a Technology Transfer Project Leader at Gestion Univalor, the technology transfer firm responsible for commercializing innovations from Université de Montréal and affiliated institutions. Currently working as an independent technology transfer professional and as part of StartUp Montreal, the local chapter of StartUp Canada, he holds a PhD in Experimental Medicine and an MSc in Microbiology & Immunology from McGill University (Montréal, QC), as well as a BSc in Microbiology from Université Laval (Québec, QC).